Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new version of the page content. This change represents a refresh of the page’s metadata and accompanying text for the study record.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision label was updated to v3.5.3, replacing v3.5.2, indicating an update to the page’s revision history rather than to study content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page shows an updated site revision label: Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check74 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check102 days agoChange DetectedFooter now displays Revision: v3.4.2; the prior government funding notice (v3.4.1) has been removed.SummaryDifference0.4%

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.